Showing results (31-40 of 124) with videos related to
Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle studyJessie A Satia, Alyson Littman, Christopher G Slatore, et al.Nutrition and Cancer|February 24, 2009
Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer StudyJessie A Satia, Marilyn Tseng, Joseph A Galanko, et al.American Journal of Epidemiology|February 12, 2009
Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) studyJessie A Satia, Alyson Littman, Christopher G Slatore, et al.The American Journal of Gastroenterology|May 10, 2003
Constipation, laxative use, and colon cancer in a North Carolina populationMalcolm C Roberts, Robert C Millikan, Joseph A Galanko, et al.Scientific Reports|June 23, 2018
Lifestyle Factors, Colorectal Tumor Methylation, and Survival Among African Americans and European AmericansEvan L Busch, Joseph A Galanko, Robert S Sandler, et al.International Journal of Cancer|March 5, 2004
Food groups and colon cancer risk in African-Americans and CaucasiansJessie Satia-Abouta, Joseph A Galanko, Christopher F Martin, et al.Clinical Transplantation|May 5, 2010
Depressive symptoms and mortality in lung transplantDonna M Evon, Eileen J Burker, Joseph A Galanko, et al.Alimentary Pharmacology & Therapeutics|September 13, 2021
Medication use and microscopic colitisRobert S Sandler, Temitope O Keku, John T Woosley, et al.Journal of Medical Internet Research|January 22, 2021
Durability of Abstinence After Completing a Comprehensive Digital Smoking Cessation Program Incorporating a Mobile App, Breath Sensor, and Coaching: Cohort StudyJennifer D Marler, Craig A Fujii, Joseph A Galanko, et al.BMC Research Notes|May 27, 2010
Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma riskKathryn E Hamilton, P Kay Lund, Joseph A Galanko, et al.Pageof 13